AG2037
Term · Oncology and biomedicine · MLC-T-ONC-000317
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called glycinamide ribonucleotide formyl transferase inhibitors.
| Identifier | MLC-T-ONC-000317 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000317",
"term": "AG2037",
"field": "Oncology and biomedicine",
"definition": "A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called glycinamide ribonucleotide formyl transferase inhibitors.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/ag2037/"
}
Record 534 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.